Rovalpituzumab

Tax included
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC).
MedChemExpress 
HY-P99043

Data sheet

Size
Multiple sizes
Reactivity
Notch
Application
Cancer-programmed cell death
CAS
1613313-01-1